Stay updated on Olezarsen in Severe Hypertriglyceridemia Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Severe Hypertriglyceridemia Clinical Trial page.

Latest updates to the Olezarsen in Severe Hypertriglyceridemia Clinical Trial page
- CheckyesterdayChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history.SummaryDifference0.0%

- Check37 days agoChange DetectedRemoved a general government operating status notice from the page, a non-content notice unrelated to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedThe new screenshot shows the same version history with a refreshed layout of the version list; no substantive study data or status changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page has updated its recruitment and revision information: old status indicators (Active, not recruiting) and the previous version (v3.1.0, dated 2025-01-29) were removed, replaced with new status entries (e.g., 74 2025-10-01 Recruitment Status Study Status), a new completion tag (Completed), a new date (2025-10-02), and a new revision (v3.2.0). Additionally, a general notice about government funding and operating status has been added.SummaryDifference10%

- Check87 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Olezarsen in Severe Hypertriglyceridemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Severe Hypertriglyceridemia Clinical Trial page.